Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Marco Ciotti and Massimo Pieri.
Marco Ciotti
Connection Strength
0.864
Massimo Pieri
  1. Serum Amyloid A Protein as a useful biomarker to predict COVID-19 patients severity and prognosis. Int Immunopharmacol. 2021 Jun; 95:107512.
    View in: PubMed
    Score: 0.233
  2. Performance of a rapid antigen test in the diagnosis of SARS-CoV-2 infection. J Med Virol. 2021 May; 93(5):2988-2991.
    View in: PubMed
    Score: 0.232
  3. SARS-CoV-2 infection serology validation of different methods: Usefulness of IgA in the early phase of infection. Clin Chim Acta. 2020 Dec; 511:28-32.
    View in: PubMed
    Score: 0.226
  4. Evaluation of S-RBD and high specificity ACE-2-binding antibodies on SARS-CoV-2 patients after six months from infection. Int Immunopharmacol. 2021 Oct; 99:108013.
    View in: PubMed
    Score: 0.060
  5. Evaluation of a new simultaneous anti-SARS-CoV-2 IgA, IgM and IgG screening automated assay based on native inactivated virus. Int Immunopharmacol. 2021 Mar; 92:107330.
    View in: PubMed
    Score: 0.058
  6. SARS-CoV-2 infection serology: a useful tool to overcome lockdown? Cell Death Discov. 2020; 6:38.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.